Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (70)	5/28/1998 2:51:00 PM
From: ChinuSFO	Read Replies (1) \| Respond to of 1722

While we all are excited about the Viagra pill, there is a drug for ED in the market that is already approved, MUSE from Vivus. Vivus is in the approval stages for their bulk manufacturing of this drug at their new manufacturing facility in New Jersey. AS soon as their new manufacturing facility gets FDA approval, they will be in a position to meet market demand. They have approval for the drug in several countries that Viagra is having problems in, Europe being one of them. It is prescribed mainly by Urologist thereby it is covered by insurance. Besides, there are no deaths reported from its use. It is a "sleeper" stock in investors' parlance and considering that it hit 80s pre-split, the current stock price indicates it is ON SALE. This is for information purposes only and is being provided so that prospective investors may do their own research before deciding to invest.